iconEarnings Announcement After Market Close

Harrow Health Inc HROW:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
6.96quote price arrow up+0.14 (+2.05%)
Volume
34,311
52 week range
5.40 - 12.99
Loading...
  • Open6.64
  • Day High7.04
  • Day Low6.64
  • Prev Close6.82
  • 52 Week High12.99
  • 52 Week High Date11/03/21
  • 52 Week Low5.40
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap188.13M
  • Shares Out27.03M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-19.44

KEY STATS

  • Open6.64
  • Day High7.04
  • Day Low6.64
  • Prev Close6.82
  • 52 Week High12.99
  • 52 Week High Date11/03/21
  • 52 Week Low5.40
  • 52 Week Low Date05/12/22
  • Market Cap188.13M
  • Shares Out27.03M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-19.44

RATIOS/PROFITABILITY

  • EPS (TTM)-0.78
  • P/E (TTM)-8.92
  • Fwd P/E (NTM)994.29
  • EBITDA (TTM)3.248M
  • ROE (TTM)-110.31%
  • Revenue (TTM)79.15M
  • Gross Margin (TTM)74.22%
  • Net Margin (TTM)-26.10%
  • Debt To Equity (MRQ)712.14%

EVENTS

  • Earnings Date08/09/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harrow Health Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Harrow Health, Inc. is an ophthalmic-focused healthcare company. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, Inc. (Visionology), a direct-to-consumer eye care subsidiary focused on chronic eye disease. In addition, the Company...
Mark Baum J.D.
Chairman of the Board, Chief Executive Officer
Andrew Boll
Chief Financial Officer, Corporate Secretary
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States

Top Peers

SYMBOLLASTCHG%CHG
CDXC
Chromadex Corp
1.92-0.07-3.52%
LJPC
La Jolla Pharmaceutical Co
6.20UNCHUNCH
SCTL
Societal CDMO Inc
1.12-0.07-5.88%
TXMD
TherapeuticsMD Inc
8.86-0.38-4.11%
PRTK
Paratek Pharmaceuticals Inc
2.61-0.15-5.43%